Tue, 2022-08-30 20:40 ABU DHABI: A real-world evidence study on the results of AstraZeneca’s Evusheld in protecting immunocompromised patients in the UAE from symptomatic COVID-19 has been launched in Abu Dhabi, the Emirates News Agency reported. The study aims to offer critical data on the safety and efficacy of the long-acting antibody combination and is one of the many outcomes of a collaboration deal signed between the Department of Health Abu Dhabi and AstraZeneca last year.Main category: Middle-East
Read More Details
Finally We wish PressBee provided you with enough information of ( New study of AstraZeneca’s Evusheld launched in Abu Dhabi )
Also on site :